Arrowhead Research Corporation is a clinical stage nanomedicine company developing innovative therapies at the interface of biology and nanoengineering. The Company has clinical programs in small RNA therapeutics and obesity. Arrowhead's programs are based on its proprietary drug development and delivery platforms, each capable of creating multiple therapeutic products. This strategy seeks to enhance the return potential for investors and reduce risk compared to traditional biotech companies. Arrowhead's world-class capabilities and intellectual property covering nucleic acid delivery, siRNA chemistry, and tissue targeting allow it to optimize therapeutic agents for a wide range of diseases.
The company's lead products include:
- CALAA-01, an oncology drug candidate based on the gene silencing RNA interference (RNAi) mechanism
- Adipotide, an anti-obesity peptide that targets and kills the blood vessels that feed white adipose tissue
- RNAi development programs for hepatitis B virus and targeting
HIF-2a for solid tumors
Arrowhead is leveraging its proprietary Dynamic Polyconjugate (DPC), Liposomal Nanoparticle (LNP), and RONDEL delivery platforms to support its own pipeline of preclinical and clinical candidates, and to secure external partnerships and collaborations with biotech and pharmaceutical companies. Arrowhead believes this comprehensive suite of delivery solutions, with its broad license to the three primary siRNA structures, positions the company as the partner of choice for small RNA therapeutics.
Learn More
Fiscal 2012 Second Quarter Financial ResultsTuesday, May 8, 2012 Alvos Acquisition Conference CallWednesday, April 11, 2012 |
Slide Presentation from the Arrowhead Annual Meeting, February 16, 2012view
|
Press Releases
NEWS RELEASE / May 9, 2012
Arrowhead Presents Data on DPC System and Hepatitis B Program at CLINAM 2012 more
NEWS RELEASE / May 8, 2012
ARROWHEAD REPORTS FISCAL 2012 SECOND QUARTER FINANCIAL RESULTS more
NEWS RELEASE / May 3, 2012
Arrowhead to Present at Series of Upcoming Scientific Conferences more
Arrowhead Research in the News

November 10, 2011
Drug Offers Hope in Obesity Fight more

November 10, 2011
Arrowhead Obesity Drug Shows Promise in Study more

November 10, 2011
Porky primates may help hefty humans slim down more

November 10, 2011
Drug Kills Fat Cells in Obese Monkeys more

November 10, 2011
Drug Based on Cancer Treatment Shows Promise for Weight Loss
more

November 9, 2011
MSNBC: Drug helps 'couch potato' monkeys lose weight. more...
View All
